What's new

EMEA-003408-PIP02-24

EMEA-003408-PIP02-24

Jun 24, 2025 - 16:30
 0
EMEA-003408-PIP02-24
EMEA-003408-PIP02-24
Read More

Tags:

Previous Article

STAT+: Abridge raises $300 million, pushing health AI deal-making to new heights

Next Article

Opinion/decision on a Paediatric investigation plan (PIP): Ebglyss, Lebrikizumab...

Related Posts

EMA roundtable with stakeholders on the 20th anniversary of the SME Regulation, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 17 October 2025, 09:30 (CEST) to 17 October 2025, 13:50 (CEST)

EMA roundtable with stakeholders on the 20th anniversar...

Jun 2, 2025  0

Human medicines European public assessment report (EPAR): Atropine sulfate FGK, atropine, Status: Opinion under re-examination

Human medicines European public assessment report (EPAR...

Jun 3, 2025  0

Human medicines European public assessment report (EPAR): Axura, memantine, Date of authorisation: 17/05/2002, Revision: 29, Status: Authorised

Human medicines European public assessment report (EPAR...

Jun 20, 2025  0